Nasopharyngeal carcinoma is a rare tumor that accounts for 1-3% of all childhood malignancies. A 16-year-old patient with refractory nasopharyngeal carcinoma, whose treatment has to be interrupted due to COVID-19 positivity.After 6 weeks because of disease progression, we started his chemotherapy altough he is still COVID-19 positive. We didn't see any complication. Prolonged COVID-19 positivity is thought to be associated with the infection of immortal malignant cells located in the nasopharynx
Journal Information
Vol. 43. Issue S3.
Pages S31 (November 2021)
Vol. 43. Issue S3.
Pages S31 (November 2021)
RARE TUMOURS AND HISTIOCYTOSISOP 40
Open Access
PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
Visits
1254
Seda Şahin, Neriman Sarı, Derya Özyörük, Sonay İncesoy Özdemir, Belgin Gülhan, İnci Ergürhan İlhan
Ankara Şehir Hastanesi
This item has received
Article information
Special issue
Case report
Full text is only aviable in PDF